AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Colorectal cancer is on the rise in adults under age 50, with incidence rates more than doubling in the U.S. since the 1990s. Research efforts aim to understand what’s driving the rise, its specific clinical and molecular features, and the best ways to diagnose and prevent this disease.
Insights from the finalists of the 2020 AACC Disruptive Technology Award competition show how IVD innovators are using artificial intelligence, novel molecular methods, and other fresh thinking to push the envelope and improve patient care.

Ask the Expert

Bench Matters

Federal Insider

Even as public attention has focused on COVID-19 vaccines, new data from AACC’s ongoing clinical laboratory survey on SARS-CoV-2 testing finds that supply shortages for testing have not let up, prompting the association to call on Congress to act.

Industry Playbook

Mammoth Biosciences has secured a four-year contract with the U.S. Department of Defense’s (DOD) Defense Advanced Research Projects Agency with MRI Global as the prime contractor, to spearhead the Detect It with Gene Editing Technologies program to develop CRISPR-based diagnostics for the DOD.

Regulatory Roundup

The Sample